NIH: SCORCH Program Expansion for Single Cell Opioid Responses in HIV Research

NIH offering funds to expand the SCORCH program exploring single cell technologies to understand molecular features of cells in Substance Use Disorders and HIV. The focus is on chronic exposures to opioids, methamphetamine, cocaine, and cannabinoids to study HIV replication, latency, and reservoirs. Closing date for applications is August 11, 2022.

Opportunity ID: 338708

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	RFA-DA-23-004
Funding Opportunity Title::	Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 – Clinical Trial Not Allowed)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Education
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 1
Posted Date::	Mar 15, 2022
Last Updated Date::	Mar 16, 2022
Original Closing Date for Applications::	Aug 11, 2022
Current Closing Date for Applications::	Aug 11, 2022
Archive Date::	Sep 16, 2022
Estimated Total Program Funding::
Award Ceiling::	$
Award Floor::	$

Eligibility

Eligible Applicants::

For profit organizations other than small businesses

Additional Information on Eligibility::

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name::	National Institutes of Health
Description::	This initiative will support exploitation of single cell technologies (transcriptome, epigenome, nucleome, and other emerging single cell assays) to identify the unique molecular features of cells involved in SUDs and/or HIV replication, latency, or reservoirs.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 1		Mar 16, 2022

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:
Competition ID:	FORMS-G
Competition Title:	Use for due dates on or after January 25, 2022
Opportunity Package ID:	PKG00272606
Opening Date:	Jul 11, 2022
Closing Date:	Aug 11, 2022
Agency Contact Information::	eRA Service Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V5.0] PHS 398 Cover Page Supplement [V5.0] Research And Related Other Project Information [V1.4] Project/Performance Site Location(s) [V4.0] Research and Related Senior/Key Person Profile (Expanded) [V4.0] PHS 398 Research Plan [V4.0] PHS Human Subjects and Clinical Trials Information [V3.0]
optional_forms	Research & Related Budget [V3.0] R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V3.0] PHS 398 Modular Budget [V1.2] PHS Assignment Request Form [V3.0]

Packages